Oragenics, Inc. (OGEN) Capital expenditures 2011–2023
Oragenics, Inc. (OGEN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$127,519FY2023 · since FY2011: $88,084 → $127,519
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $127,519 | +190.6% |
| FY2022 | $43,876 | — |
| FY2020 | $25,214 | -79.8% |
| FY2019 | $124,727 | — |
| FY2017 | $27,179 | -73.5% |
| FY2016 | $102,511 | -7.4% |
| FY2015 | $110,673 | +488.4% |
| FY2014 | $18,809 | +69.5% |
| FY2013 | $11,095 | — |
| FY2011 | $88,084 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice